Business · 23/05/1994Updated: 10/16/2026 · 1 min read

Availability of Letter Concluding Consultation from FDA to Calgene, Inc.

Summary

The FDA announces the availability of a letter and a written summary regarding the consultation with Calgene, Inc. over FLAVR SAVR TM tomatoes, concluding that they have not been significantly altered.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Business · 9/15/2026

National Cancer Institute Announces Closed Meeting

The National Cancer Institute has issued a notice regarding a closed meeting, which is not open to the public.

Read summary →

Business · 9/16/2026

Microbiology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Pathogen-Agnostic Sequencing

The Food and Drug Administration (FDA) announces a public advisory committee meeting of the Microbiology Devices Panel to discuss pathogen-agnostic sequencing for emergency preparedness and response efforts.

Read summary →

Business · 9/16/2026

Food and Drug Administration Announces Proposed Collection of Information for Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Read summary →

Business · 9/16/2026

Government-Owned Inventions; Availability for Licensing

The National Institute of Allergy and Infectious Diseases (NIAID) is giving notice of a government-owned invention available for licensing to achieve commercialization of federally funded research results.

Read summary →

Business · 9/14/2026

Office of the National Coordinator for Health Information Technology; Health Information Technology Advisory Committee; Amended Notice of Meeting

The Office of the National Coordinator for Health Information Technology and the Health Information Technology Advisory Committee have issued an amended notice regarding a meeting, which appears to be a formal announcement of a scheduled event.

Read summary →